Skip to main content
Signal8

Houston John G

SEC insider (Form 3/4/5 filer). CIK 0001753537. Director at NextCure, Inc. (NXTC) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in BELTSVILLE, MD.

Companies Houston John G has filed insider reports for

  • NextCure, Inc. (NXTC): Director
  • ARVINAS, INC. (ARVN): Director
Houston John G profile photo

Houston John G

CIK: 0001753537

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (62.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NextCure, Inc. logo
NXTC

NextCure, Inc.

Director
ARVINAS, INC. logo
ARVN

ARVINAS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • NextCure, Inc. logo
    NXTC

    NextCure, Inc.

    Jun 18, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    2.3K shares-
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Feb 27, 2026
    Sale
    Direct
    18.8K shares at avg. $13.24$249K
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Feb 27, 2026
    Sale
    Direct
    4.7K shares at avg. $13.24$62K
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Feb 27, 2026
    Sale
    Direct
    11.8K shares at avg. $13.14$155K
  • NextCure, Inc. logo
    NXTC

    NextCure, Inc.

    Jun 20, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    18.7K shares-
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Feb 24, 2025
    Sale
    Direct
    26.2K shares at avg. $16.75$439K
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Feb 24, 2025
    Sale
    Direct
    5.2K shares at avg. $16.55$85K
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Feb 13, 2025
    Award
    Direct
    152K shares-

1-8 of 8